Search

everythinglearnresearchcommunity

for

Search:↓

Certain factors like allergies, nail problems, and hair loss patterns can predict how well someone with patchy hair loss will respond to skin cream treatments.

Lack of vitamin D might cause hair loss due to autoimmune problems, and fixing vitamin D levels could help treat it.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

Hair follicles could be used to noninvasively monitor our body's internal clock and help identify risks for related diseases.

Premature graying of hair is often linked with other health issues, but treatment with biotin, zinc, and calcium pantothenate is not very effective.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Women with PCOS have higher levels of thyroid autoantibodies.

People with alopecia areata may also have allergic rhinitis and should be checked for respiratory allergies.

Alopecia areata mainly affects young people, often showing as patchy hair loss on the scalp.

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

The article suggests that five common skin-related lab tests may be unnecessary and could cause extra cost and anxiety without improving patient care.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Thyroid problems can cause hair loss and change hair texture.

Premature graying of hair may suggest health issues and currently lacks effective treatments.

Losing eyelashes or eyebrows can be a sign of many different health problems and needs a careful approach to treat effectively.

A mother and son both had ulcerative colitis and alopecia, suggesting a genetic link in autoimmune disorders and successful treatment with cyclosporine.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

The conclusion is that early diagnosis of skin signs linked to diseases like Lupus, Dermatomyositis, and Rheumatoid Arthritis is crucial to prevent serious complications.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Alopecia areata is complex, often recurring, and needs personalized treatment, especially with other health issues.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

Some vaccines, like the hepatitis B vaccine, might be linked to the hair loss condition Alopecia Areata, but more research is needed.

No cure exists for alopecia areata, and treatments are personalized.

Alopecia areata is relatively common in children, has a variable course, and shows different responses to treatment; thyroid testing is recommended for those affected.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Gut bacteria may affect hair loss in people with celiac disease.

The skin's bacteria might influence the development of a hair loss condition called alopecia areata.